Journal Detail Information

1

Cite

Share

A Case of Leiomyomatosis peritonealis disseminata.

Myeng Chan CHOU ; Beak Keun YOO ; Hyun Cheol SHIN ; Keum Won LEE ; Tae Sung CHO ; Dong Han BAE ; Yong Woo SHIN

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(1):125-129.

Leiomyomatosis peritonealis disseminata is a rare non-neoplastic proliferation of histologically benign smooth muscle that occurs in the alxlominal cavity of during the reproductive years of life, often giving rise to false choical imprwsion of d.isseminated carcinomatosis grossly, In 1952 Wilson & Peale described a condition which they called "multiple peritoneal leiomyomas". Taubert et al(1965) clearly delinated the features of the lesion and named it leiomyomatosis peritonealis disseminata(LPD). We report a case of leiomyomatosis peritonealis disseminata with a brief review of literatures.
Carcinoma ; Leiomyomatosis* ; Muscle, Smooth

2

Cite

Share

Multiple Primary Carcinoma Associated with Gynecologic Malignancies.

Cheol Ho LEE ; Beak Keun YOO ; Myeng Chan CHOU ; Keum Won LEE ; Jeong Jae LEE ; Kae Hyun NAM ; Kwon Hae LEE

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(1):103-108.

Sixteen multiple primary carcmomas were found in 674 patients with gynecologic malignancies who were treated in our departiment from 1980 to 1992. Cases with possible metastasis or recurrence were not included in this study, The incidence of rnultiple primary carcinomas in gynecologic rnalignancies was 2.1%, Multiple primary carcinomas were encountered in 2.4% of 674 cervical cancers, 1.4% of 73 ovarian cancers respectively. The most frequent sites of uther cancers were seen in the stomach(5/16) and lung(3/l6).
Humans ; Incidence ; Neoplasm Metastasis ; Ovarian Neoplasms ; Recurrence

3

Cite

Share

Transvaginal Sonography as a Screening Method for Ovarian Cancer (I).

Kae Hyun NAM ; Kwon Hae LEE

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(1):89-96.

Utrasonic evaluation has been suggested as a screening method for early ovarian cancer. This study was designed to evaluate the aceuracy of pelvic ultraesound to measure the ovarian volume as the preliminary study. The ovarian volume me ured. by ultrasound was compared with findings at. surgery. Subjects far this investigation were 25 menstruating patients and 12 climacteric patients who were scheduled for gynecologic surgery chiefly unrelated to adnexal masses. The mean nf ovarian volume with menstruating patients was 5.7+/-5.9cm3 and that of climacteric patients was 2.5+/-l.3cm3(P<0.01). The eorrelation coefficient between the ovarian volurne measurement made by two examiners was 0.80. The correlation coeffieient between the ovarian volume measured by transvaginai ultrasonography and ovarian volume at laparotomy was 0. 37 and poor, The ll ovaries(52%) among the 24 ovaries of 12 climacteric tients were not visualized. So, this study suggested that the ovarian volume measurements af the postmenopauml by transvaginal ultrasonograpy was not simple and demanded the skill and laboraus training.
Climacteric ; Female ; Gynecologic Surgical Procedures ; Humans ; Laparotomy ; Mass Screening* ; Ovarian Neoplasms* ; Ovary ; Ultrasonography

4

Cite

Share

Analysis of prognostic factors associated with the treatment failures in stage IB and IIA carcinoma of the uterine cervix.

Seon Kyung LEE ; Jae Hyun LEE ; Jung Eun MOK

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(1):76-88.

One hundred fifty-seven patients wha underwent radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB and IIA carcinoma of the cervix between February l975 and May 1987 were retros-pectively analysed to identify specific risk factors associsted with treatment failures. Prognostic factors inciuded clinical stage, histologic cell type, degree of differentiation, size of primary tumor, depth of stromal invasian, lymph-vaseular space invasion, and lymph node metastasis. Treatment results were evaluated according to the recurrence rate and 2-year absolute recurrence-free survival(NED) rate by the prognostie faetors and treatment modalities. Patients with lymph node me tases had a significantly higher incidence of bulky primary(-> 4cm), depth of stromal invasion(> 60% thickness), and lymph-vascular invasion(P<0.005). There was significant difference in the recurrence rate and 2-year, NED rate between cervical carcinoma stage IB and I1A(P <0.005). The pat,ients who had bulky primary tum~or(>4cm) and/or depth of stromal invasion (>60% thickness) had a higher recurrence and lower 2-year NKD rate(P<0.025, P<0.005), Unfortunately, it was not possible to demonstrate that these detrimentel effects could be overeorne by postoperetive radiation. When adjoined for these risk group, traditionally reported poor prognostic factors such as nodal metatasis, cell type and differentiation, lyrnphi-vascular mvasion assume less importance in our studies. In this study, prognosis is most inf1ueneed by clinical stage, depth of stromal invasion, and size of primary tumor,
Cervix Uteri* ; Female ; Humans ; Hysterectomy ; Incidence ; Lymph Node Excision ; Lymph Nodes ; Neoplasm Metastasis ; Prognosis ; Recurrence ; Risk Factors ; Treatment Failure*

5

Cite

Share

An Immunohistochemical Study for the ras and neu Oncoprotein and Epidermal Growth Factor Receptor in the Uterine Cervical Carcinoma.

Min Seog LEE ; Il Soo PARK

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(1):43-55.

To evaluate the expression of ras, neu oncoprotein a.nd epidermal growth factor receptor (EGFR) on uterine cervieal carcinoma, imimunohistochemieal staining was performed on 9 cases of dysplasia, 39 cases of careinoma in situ(CIS), 32 cases of microinvasive earcinoma(WIC) and 60 cases of frankly invasive carrinoma(FIC). The results obtained were as follows: Ras p21 protein was positive in 29.5% of total cases, and it was very low in dysplasia lesion(12. 5%) and CLS(17.9%) while it was high in MIC(31.3%) and FIC(38.9%). In CIS, parabasal cell type showed positive reaction in only 8.7%, but pleomorpkic type showed 60.0% positivity. Invasive carcinoma showed no significant differences between histolegic types. Expression of neu protein was very high in caneerous group(around 95%) and slight,ly lower in dysp]asia(75.0%). No differences were found depending on histologic types and stages. EGFR was expressed in 51.8% of total cases; 12.5% of dysplasia; 54.2% of all cases of carcinoma. Keratinizing type of CIS showed highest positive reaction(90,0%), of which tendency were also noted in keratinizing type of i.nvasvie cinoma(76.2%). The results suggested that ras and EGFR could be used as a factor of prognostic value.
Epidermal Growth Factor* ; Receptor, Epidermal Growth Factor*

6

Cite

Share

An Immunohistochemical study on distribution of natural killer(NK) cell in patients with cervical dysplasia and cervical cancer.

Kyu Wan LEE ; Hai Joong KIM ; Pyoung Sam KU ; Bom Woo YEOM

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(1):19-31.

Natural Killer (NK) cells are a subpopulation of in vivo activated lymphocytes that display spontaneous cytotoxicity against a variety of targets as virus-infeeted, and transformed neoplastic cells, in major histocompatibility-unrestricted fashion. Depression of the NK aetivity in patients with advanced stages of various types of solid neopls,sms appears to be dependent upon the prcgressive growth and metastatic spread of the tumor. There are many reports that different distribution of subpopulations of lymphocytes in neopiastic tissue may influence the prognosis of the patients, In this study, we have performed immunohistochemieal study with Leu-7, MT1, LN2, and antilysozyrne antiserum on the tissue of uterine cervieal dysplasia and cancer to investigate the distribution of the NK cell, T cell, B cell, and macrophage. The results were as follows ; 1. The major subpopulation of lymphocytes infiltrating the lesion of intraepithelial neoplasia and squamous cell carcinama was T cell. 2. The number of infiltrated. lymphocytes was layer in the lesion of keratinzing type than in that of non keratinizing and small cell earcinorna of the uterine cervix. 3. NK cell was more frequently noted in the malignant lesion than the dysplastic lesion.
Cervix Uteri ; Depression ; Female ; Humans ; Killer Cells, Natural ; Lymphocytes ; Macrophages ; Prognosis ; Uterine Cervical Neoplasms*

7

Cite

Share

The Detection of the p53 Protein in Cervical Cancer and CIN by Immunohistochemistry.

Heung Gon KIM ; Gi Uk CHOI ; Gi Youn HONG ; Hee Sub RHEE ; Bu Kie MIN ; Ki Suck KIM ; Hyung Bae MOON

Korean Journal of Gynecologic Oncology and Colposcopy.1995;6(1):23-30.

The cell cycle is composed of a series of steps which can be negatively or positively regulated by various factors. p53 gene aberrations are common in human malignancies, and recent studies suggest that in cervical carcinoma p53 function is inactivated either by complex formation wilh human papilloma virus (HPV) E6 product or by gene mutation. To study the expression of p53 gene in the cervical cancer and cervical intraepithebal neoplasia, immunohistochemistry for the p53 protein was done in the 47 cases of squamous cell carcinoma, 6 cases of adenocarcinoma and 32 cases of cervical intraepithelial neoplasia. I. The p53 protein was detected in the 31% of cervical intraepithelial neoplasia (10/32 cases). 2. The p53 protein was detected in the 55% of invasive cervical cancer (29/53 cases). 3. By the histologic type of cervieal cancer, the p53 protein was detected in the 57% of squamous cell carcinoma (27/47 cases) and 33% of(2/6 cases) adenocarcinoma. The p53 protein wes more frequently detected in the squamous cell carcinoma than in the adenocarcinoma. 4. By the staging in cervical cancer, the p53 protein was detected in the 31% of stage 0, 50% of Stage Ia, 50% of stage I b, 75% of IIa and 50% of stage II b.
Adenocarcinoma ; Carcinoma, Squamous Cell ; Cell Cycle ; Cervical Intraepithelial Neoplasia ; Genes, p53 ; Humans ; Immunohistochemistry* ; Papilloma ; Uterine Cervical Neoplasms*

8

Cite

Share

Invasive Cervical Cancer in Women Aged 35 or Less.

Eun Hee CHYU ; Won Gue KIM ; Un Dong PARK

Korean Journal of Gynecologic Oncology and Colposcopy.1995;6(1):13-22.

The incidence in women less than 35 years of age is increasing despite an overall decrease in newly diagnosed invasive cervieal cancer among all age groups. However the influence of young age on prognosis remains controversial. So 163 patients of invasive cervical cancer in women aged 35 or less treated from Jan. 1, 1984 to Dec. 31. 1993 at the Department of Obstetrics and Gynecology, Kosin Medical College, Pusan, Korea, were studied retrospectively. We obtained the following results; The 5-year survival rates by clinical stage were 88.7Y% in stage I b, 71.5% in stage IIa, 31.2% in stage IIb and O% in stage III or above. The lymph node metastasis rates by stage in RAH group, were 21.3% in stage I b and 31.8% in stage IIa. The lymph nodc metastasis rates by lesion size in RAH group, were 19.2% in 2cm below, 20.7% in 2-4cm and 40.0% in 4cm above. The 5-year survival rates in RAH group were 74,9% in lymph node positive group and 89.0% in lymph node negative group. The recurrenee rates by clinieal stage were 0% in stage Ia, 20.6% in stage I b, 22.2% in stage IIa, 50.0% in stage Ilb and 90.9% in stage III or above.
Busan ; Female ; Gynecology ; Humans ; Incidence ; Korea ; Lymph Nodes ; Neoplasm Metastasis ; Obstetrics ; Prognosis ; Retrospective Studies ; Survival Rate ; Uterine Cervical Neoplasms*

9

Cite

Share

Clinical Significance of p53 Gene Expression with Immunohistochemical Staining in Ovarian Cancer.

Jae Wook KIM ; Yeun Hae LEE ; Young Tae KIM ; Chung Pil LEE ; Dong Kyu KIM ; Chan Ho SONG

Korean Journal of Gynecologic Oncology and Colposcopy.1995;6(1):7-12.

Mutation of p53 gene is one of t.he commonest genetic changes in the development of human cancer including ovary. We intvestigated the diagnostic usefulness of the demonstration of p53 gene immunoreactivity in ovarian cancers, because immunochemical demonstration of p53 immunoreactivity is inexpensive, easily controlled and can be applied in routine pathology laboratories. p53 immunoreactivity was not identified in any patients in whom there was no morphological evidence of neoplasia. ln contrast, in contrast, in 46% of patients of ovarian cancer, p53 immunoreactivity was identified. Overexpression of gene correlated with advanced stage but did not corre1ate with grade, cell type and tumor size.
Female ; Genes, p53* ; Humans ; Immunohistochemistry ; Ovarian Neoplasms* ; Ovary ; Pathology

10

Cite

Share

A case of endodermal sinus tumor of ovary ; Complete remission & full-term delivery after conservative surgery and BEP therapy.

Woo Gyeong KIM ; Kyung Bok LEE ; Moon Su SUNG ; Ki Tae KIM ; Hyun Chan KIM

Korean Journal of Gynecologic Oncology and Colposcopy.1998;9(4):504-508.

The endodermal sinus tumor of ovary is a rare, malignant germ cell tumor. It principally affects children and young adults. Earlier reports before combination chemothery described it was fatal and the prognosis was poor. The advances in treatment of endodermal sinus tumor have been achieved with the development of combination chemotherapy with monitoring tumor marker, serum AFP. The authors experienced a case of endodermal sinus tumor of ovary which showed complete remission following primary conservative surgery and three courses of combination chemotherapy(BEP) with normal full-term spontaneous delivery. With the case report, a brief review was made.
Biomarkers ; Child ; Drug Therapy, Combination ; Endoderm* ; Endodermal Sinus Tumor* ; Female ; Humans ; Neoplasms, Germ Cell and Embryonal ; Ovary* ; Prognosis ; Young Adult

DISPLAY OPTIONS

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share